Clinical Trials in Pittsburgh

Showing 14261-14280 of 18,076 trials

Preference and Vegetarian Diet in Weight Loss Treatment

NCT00330629

We propose to add a treatment preference component to a larger study testing standard behavioral treatment (SBT) for weight loss without specific food group restriction vs standard behavioral treatment with gradual elimination of meat, poultry, and fish \[a lacto-ovo-vegetarian (LOV) meal plan\]. Eligible respondents will be randomized to one of two conditions: Treatment Preference-Yes/No. Individuals in the Treatment Preference-Yes will be assigned to their choice (SBT or SBT+LOV), those in Treatment Preference-No will be randomized to either SBT or SBT+LOV without regard to their preference.

ObesityOverweight

University of Pittsburgh200 participantsStarted Jan 2002

Pittsburgh, Pennsylvania, United States

COMPLETEDPhase 2< 1 mile

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma

NCT00053885

RATIONALE: PTK787/ZK 222584 may stop the growth of tumor cells by blocking the enzymes necessary for tumor cell growth. PURPOSE: Phase II trial to study the effectiveness of PTK787/ZK 222584 in treating patients with unresectable malignant mesothelioma.

Malignant Mesothelioma

Alliance for Clinical Trials in Oncology47 participantsStarted Jul 2003

Anniston, Alabama, United States • Birmingham, Alabama, United States • La Jolla, California, United States +77 more locations

Preference and Vegetarian Diet in Weight Loss Treatment

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma

Find Trials by Condition in Pittsburgh

A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC

Evaluation of Group Lifestyle Balance DVD in Primary Care Practice

Glycopyrrolate/Formoterol Fumarate MDI Compared With Spiriva® as An Active Control in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke

Homoharringtonine Compared With Hydroxyurea for Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa

Expanded Access Program for Maraviroc At Multiple Centers

Diagnostic Study of Gene Alterations in Patients With Acute Myeloid Leukemia

Sentinel Lymph Node Mapping in Detecting Cancer That Has Spread to Lymph Nodes in Patients With Non-Small Cell Lung Cancer

Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer

Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia

Peak Study - A Study of Pegasys (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC).

Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer

A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients

A Study of Two Fabrazyme (Agalsidase Beta) Dosing Regimens in Treatment-naïve, Male Pediatric Patients Without Severe Symptoms

Identifying Cancer Genes in in Blood and Bone Marrow Samples From Patients With Acute Myeloid Leukemia

Phase II Study of Skin Toxicity Dosing of IRESSA (Gefitinib) in Squamous Cell Carcinoma of the Head and Neck

A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia